Epidemiology of heart failure in Germany: a retrospective database study

Clinical Research in Cardiology

Volumn 106, Issue 11, 2017, Pages 913-922

  Störk, Stefan ^a,f   Handrock, Renate ^b   Jacob, Josephine ^c,d   Walker, Jochen ^c,d   Calado, Frederico ^e   Lahoz, Raquel ^e   Hupfer, Stephan ^b   Klebs, Sven ^b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b Novartis Pharma GmbH   (Germany)

^c ELSEVIER MASSON   (France)

^d Health Risk Institute   (Germany)

^e NOVARTIS PHARMA AG   (Switzerland)

^f Deutsches Zentrum für Herzinsuffizienz Würzburg   (Germany)

Author keywords

Epidemiology; Germany; Heart failure; Incidence; Prevalence

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCOSIDE;

ADULT; AGED; ARTICLE; CHARLSON COMORBIDITY INDEX; FEMALE; GERMANY; HEALTH INSURANCE; HEART FAILURE; HOSPITALIZATION; HUMAN; INCIDENCE; INFORMATION RETRIEVAL; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; PRESCRIPTION; PREVALENCE; RETROSPECTIVE STUDY; VERY ELDERLY; CLINICAL TRIAL; FACTUAL DATABASE; FOLLOW UP; MULTICENTER STUDY; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR;

AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 85026918454     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-017-1137-7     Document Type: Article

References (25)

1. Roger VL (2013) Epidemiology of heart failure. Circ Res 113:646–659
2. Braunwald E (1997) Shattuck lecture—cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337:1360–1369
3. Bui AL, Horwich TB, Fonarow GC (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8:30–41
4. Cowie MR, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Suresh V, Sutton GC (1999) Incidence and aetiology of heart failure; a population-based study. Eur Heart J 20:421–428
5. Ho KK, Pinsky JL, Kannel WB, Levy D (1993) The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22:6a–13a
6. Zarrinkoub R, Wettermark B, Wandell P, Mejhert M, Szulkin R, Ljunggren G, Kahan T (2013) The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur J Heart Fail 15:995–1002
7. Tiller D, Russ M, Greiser KH et al (2013) Prevalence of symptomatic heart failure with reduced and with normal ejection fraction in an elderly general population-the CARLA study. PLoS One 8:e59225
8. Ohlmeier C, Mikolajczyk R, Frick J, Prutz F, Haverkamp W, Garbe E (2015) Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons. Clin Res Cardiol 104:688–696
9. Neumann T, Biermann J, Erbel R, Neumann A, Wasem J, Ertl G, Dietz R (2009) Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int 106:269–275
10. Christ M, Stork S, Dorr M, Heppner HJ, Muller C, Wachter R, Riemer U, For the Trend HF Germany Project (2016) Heart failure epidemiology 2000-2013: insights from the German Federal Health Monitoring System. Eur J Heart Fail 18:1009–1018
11. Schmid T, Xu W, Gandra SR, Michailov GV (2015) Costs of treating cardiovascular events in Germany: a systematic literature review. Health Econ Rev 5:27
12. Andersohn F, Walker J (2016) Characteristics and external validity of the German Health Risk Institute (HRI) Database. Pharmacoepidemiol Drug Saf 25:106–109
13. Informed Health Online (2015) Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG). Health care in Germany: health insurance in Germany. https://www.ncbi.nlm.nih.gov/books/NBK298832/?report=reader#_NBK298832_pubdet. Accessed 27 Mar 2017
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
15. Pasternak B, Mattsson A, Svanstrom H, Hviid A (2015) Comparative effectiveness of bisoprolol and metoprolol succinate in patients with heart failure. Int J Cardiol 190:4–6
16. Statistisches Bundesamt (ed) (2012) Diagnosedaten der Patienten und Patientinnen in Krankenhäusern (einschl. Sterbe- und Stundenfälle), Fachserie 12 Reihe 6.2.1
17. Svanstrom H, Pasternak B, Melbye M, Hviid A (2015) Use of different types of angiotensin converting enzyme inhibitors and mortality in systolic heart failure. Int J Cardiol 182:90–96
18. Schwabe U, Paffrath D (2012) Arzneiverordnungs-Report. Springer, Berlin
19. Leitlinien und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP) (2009) Deutsche Gesellschaft für Epidemiologie
20. Gute Praxis Sekundärdatenanalyse (GPS) Leitlinien und Empfehlungen (3. Fassung) (2012) Arbeitsgruppe Erhebung und Nutzung von Sekundärdaten (AGENS), Deutschen Gesellschaft für Sozialmedizin und Prävention (DGSMP), Deutschen Gesellschaftfür Epidemiologie (DGEpi) (eds)
21. Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, Hofman A, Grobbee DE (1999) Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J 20:447–455
22. Maggioni AP, Anker SD, Dahlstrom U et al (2013) Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC heart failure long-term registry. Eur J Heart Fail 15:1173–1184
23. McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847
24. Metra M, Zaca V, Parati G et al (2011) Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure. J Cardiovasc Med (Hagerstown) 12:76–84
25. Khunti K, Hearnshaw H, Baker R, Grimshaw G (2002) Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. Eur J Heart Fail 4:771–777